The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000527.5(LDLR):c.1705+2T>C

CA404089507

440656 (ClinVar)

Gene: LDLR (HGNC:3949)
Condition: hypercholesterolemia, familial (MONDO:0007750)
Inheritance Mode: Semidominant inheritance
UUID: 54c85436-b1d2-492c-8f22-a6e78eb8c415
Approved on: 2026-01-23
Published on: 2026-07-14

HGVS expressions

NM_000527.5:c.1705+2T>C
NM_000527.5(LDLR):c.1705+2T>C
NC_000019.10:g.11116214T>C
CM000681.2:g.11116214T>C
NC_000019.9:g.11226890T>C
CM000681.1:g.11226890T>C
NC_000019.8:g.11087890T>C
NG_009060.1:g.31834T>C
ENST00000252444.10:c.1963+2T>C
ENST00000559340.2:c.1705+2T>C
ENST00000560467.2:c.1585+2T>C
ENST00000558518.6:c.1705+2T>C
ENST00000252444.9:c.1959+2T>C
ENST00000455727.6:c.1201+2T>C
ENST00000535915.5:c.1582+2T>C
ENST00000545707.5:c.1324+2T>C
ENST00000557933.5:c.1705+2T>C
ENST00000558013.5:c.1705+2T>C
ENST00000558518.5:c.1705+2T>C
ENST00000559340.1:c.426+2T>C
NM_000527.4:c.1705+2T>C
NM_001195798.1:c.1705+2T>C
NM_001195799.1:c.1582+2T>C
NM_001195800.1:c.1201+2T>C
NM_001195803.1:c.1324+2T>C
NM_001195798.2:c.1705+2T>C
NM_001195799.2:c.1582+2T>C
NM_001195800.2:c.1201+2T>C
NM_001195803.2:c.1324+2T>C
More

Likely Pathogenic

Met criteria codes 2
PVS1 PM2
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1705+2T>C variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PVS1 and PM2 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 23, 2026. The supporting evidence is as follows: PM2: This variant is absent from gnomAD v4.1.0. PVS1: Variant is in canonical +2 GT splice site that predicts exon 11 skipping and disruption to reading frame.
Met criteria codes
PVS1
Variant is in canonical +2 GT splice site that predict a frameshift in exon 11
PM2
This variant is absent from gnomAD v4.1.0
Not Met criteria codes
PP4
No cases of the variant segregating in FH were found in the literature.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.